H
300086
vs
S
Shanghai Composite
Over the past 12 months, Honz Pharmaceutical Co Ltd has significantly outperformed Shanghai Composite, delivering a return of +85% compared to the Shanghai Composite's +22% growth.
Stocks Performance
300086 vs Shanghai Composite
Performance Gap
300086 vs Shanghai Composite
Performance By Year
300086 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Honz Pharmaceutical Co Ltd
Glance View
Honz Pharmaceutical Co., Ltd. engages in the manufacture and distribution of drugs for children. The company is headquartered in Haikou, Hainan and currently employs 872 full-time employees. The company went IPO on 2010-05-26. The firm provides western medicines and Chinese patent drugs, including antipyretic and analgesic drugs, cold drugs, antibiotics drugs, respiratory system drugs, digestant and arresting convulsion drugs, as well as nutrition drugs, among others. The firm's products include nimesulide granules, cefminox sodium for injection, Zhike Juhong granules, Ganmao Qingre granules, artificial cow-bezoar and chlorphenamine maleate granules, cefaclor granules, carbocisteine granules, Jianerle granules, pediatric four vitaminsand calcium gluconate granules, as well as ribavirin pellets and Norfloxacin capsules for adults.
